Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Factors specific for lectin pathway of complement activation in patients with haematological malignancies, receiving autologous haematopoietic stem cell transplantations

2013/11/B/NZ6/01739

Keywords:

lectin pathway complement haematology innate immunity infection

Descriptors:

  • NZ6_1: Adaptive and innate immunity
  • NZ6_2: Clinical immunology

Panel:

NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution :

Instytut Biologii Medycznej Polskiej Akademii Nauk

woj. łódzkie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr hab. Maciej Cedzyński 

Number of co-investigators in the project: 14

Call: OPUS 6 - announced on 2013-09-16

Amount awarded: 846 840 PLN

Project start date (Y-m-d): 2014-11-04

Project end date (Y-m-d): 2018-11-03

Project duration:: 48 months (the same as in the proposal)

Project status: Project settled

Equipment purchased [PL]

  1. pH-metr z wyposażeniem.
  2. komora laminarna klasy 2 (58 000 PLN)

Information in the final report

  • Publication in academic press/journals (5)
  1. Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults
    Authors:
    Sokołowska A, Świerzko AS, Gajek G, Gołos A, Michalski M, Nowicki M, Szala-Poździej A, Wolska-Washer A, Brzezińska O, Wierzbowska A, Jamroziak K, Kowalski ML, Thiel S, Matsushita M, Jensenius JC, Cedzyński M.
    Academic press:
    Scientific Reports (rok: 2020, tom: 10, strony: 10561), Wydawca: Nature Research
    Status:
    Published
    DOI:
    10.1038/s41598-020-67516-2 - link to the publication
  2. Associations of ficolins with haematological malignancies in patients receiving high-dose chemotherapy and autologous haematopoietic stem cell transplantations (auto-HSCT).
    Authors:
    Świerzko AS, Michalski M, Sokołowska A, Nowicki M, Szala-Poździej A, Eppa Ł, Mitrus I, Szmigielska-Kapłon A, Sobczyk-Kruszelnicka M, Michalak K, Gołos A, Wierzbowska A, Giebel S, Jamroziak K, Kowalski ML, Brzezińska O, Thiel S, Matsushita M, Jensenius JC, Gajek G, Cedzyński M.
    Academic press:
    Frontiers in Immunology (rok: 2020, tom: 2020 Jan 28; 10, strony: 3097), Wydawca: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2019.03097 - link to the publication
  3. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
    Authors:
    Świerzko AS, Michalski M, Sokołowska A, Nowicki M, Eppa Ł, Szala-Poździej A, Mitrus I, Szmigielska-Kapłon A, Sobczyk-Kruszelnicka M, Michalak K, Gołos A, Wierzbowska A, Giebel S, Jamroziak K, Kowalski ML, Brzezińska O, Thiel S, Jensenius JC, Kasperkiewicz K, Cedzyński M
    Academic press:
    Frontiers in Immunology (rok: 2018, tom: 2018 Sep 20;9, strony: 2153), Wydawca: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2018.02153 - link to the publication
  4. Znaczenie czynników aktywacji dopełniacza na drodze lektynowej w chorobach nowotworowych
    Authors:
    Cedzyński M., Świerzko A.S.
    Academic press:
    Journal of Health Study and Medicine (rok: 2017, tom: 5, strony: 13332), Wydawca: SAN
    Status:
    Published
  5. Components of the lectin pathway of complement in haematologic malignancies.
    Authors:
    Cedzyński M., Śwsierzko A.S.
    Academic press:
    Cancers (rok: 2020, tom: 12, strony: 1792), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers12071792 - link to the publication